APA (7th ed.) Citation

ES, V., J, S., X, H., K, G., EN, C., JM, R., . . . BG, D. (2026). Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer. MedRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.01.21.26344294

Chicago Style (17th ed.) Citation

ES, Villodre, et al. "Serum S100A8/S100A9 Is Associated with Increased Risk of Brain Metastasis in Patients with Inflammatory Breast Cancer." MedRxiv : The Preprint Server for Health Sciences 2026. https://doi.org/10.64898/2026.01.21.26344294.

MLA (9th ed.) Citation

ES, Villodre, et al. "Serum S100A8/S100A9 Is Associated with Increased Risk of Brain Metastasis in Patients with Inflammatory Breast Cancer." MedRxiv : The Preprint Server for Health Sciences, 2026, https://doi.org/10.64898/2026.01.21.26344294.